NRG1271
NRG1271 is an orally active mitochondrial permeability transition pore (mPTP) inhibitor with blood-brain barrier penetration. NRG1271 can be used for the study of Neurological Disease[1].
Product Specifications
CAS Number
[3077720-24-9]
UNSPSC
12352005
Target
Mitochondrial Metabolism
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Neurological Disease
Purity
98.86
Solubility
DMSO : 5 mg/mL (ultrasonic)
Smiles
FC1=C2C(C=NN2)=CC=C1/C=C(F)/C(NC3=C(C)N=CC(F)=C3C)=O
Molecular Formula
C17H13F3N4O
Molecular Weight
346.31
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15099262 1 Vial
Lentiviral human NQO1 shRNA (UAS) - Lentiviral human NQO1 shRNA (UAS, GFP) plasmid
Ask
View Details 
12-4157-10 10 Tests
Phospho-PI3 Kinase p85 (Tyr458) /p55 (Tyr199) (Clone: 1A11) rabbit mAb APC conjugate
Ask
View Details